{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-002307","form_type":"8-K","ticker":"ULBI","cik":"0000875657","company_name":"ULTRALIFE CORP","filed_at":"2022-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.116348+00:00","generated_at":"2026-06-27T12:05:36.225609+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ultralife Q4 revenue $23.8M, operating loss $1.2M; supply chain delays impacted results","bullets":["GAAP net loss $1.1M ($0.07 loss per share) vs net income $2.1M ($0.13 EPS) in Q4 2020.","Revenue down 18% to $23.8M; delayed shipments from supply chain issues reduced revenue by ~$5.4M.","Backlog grew 35% core YoY to >$53M; over $63M including Excell acquisition.","FY2021 GAAP EPS ($0.01), Adjusted EPS ($0.02) vs FY2020 GAAP EPS $0.33, Adjusted EPS $0.41.","Acquisition of Excell Battery Group in Dec 2021 added initial revenue but also $0.5M in one-time expenses and purchase accounting adjustments."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-002307","json":"https://secwatch.observer/filing/0001437749-22-002307.json","markdown":"https://secwatch.observer/filing/0001437749-22-002307.md","text":"https://secwatch.observer/filing/0001437749-22-002307.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875657/000143774922002307/0001437749-22-002307-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875657/000143774922002307/ulbi20220203_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T12:05:36.225609+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}